“…During the last decade, several candidate TSGs at 3p21.3 have been identified and characterized, including RASSF1A [Ras association (RalGDS/AF-6) domain family member 1], GNAT1 [guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1], BLU (zinc finger, MYND-type containing 10), and LARS2 (leucyl-tRNA synthetase 2, mitochondrial), which are inactivated by promoter hypermethylation and/or LOH in NPC [36] - [40] . Several other TSGs at 3p have been identified, including NAG7 (long intergenic non-protein coding RNA 312) at 3p25 [41] , LTF (lactotransferrin) at 3p21 [42] , [43] , FBLN2 (fibulin 2), TMEM45A (transmembrane protein 45A), ZIC4 (Zic family member 4), GPR149 (G protein-coupled receptor 149), and ETV5 (ets variant 5) [44] . Recently, in our laboratory, candidate TSGs CACNA2D3 (calcium channel, voltage-dependent, alpha 2/delta subunit 3) at 3p21.1, RBMS3 (RNA-binding motif, single stranded interacting protein 3) at 3p33, and CHL1 [cell adhesion molecule with homology to L1CAM (close homolog of L1)] at 3p26 have been identified (unpublished data) (Table 2).…”